4
Changes in Ownership
ENDRA Life Sciences Inc. Filed Acc 0001209191-20-064584
Chief Commercial Officer sold 25,000 shares at $0.73 ($18,250)
From the SEC's structured data for this filing
Trades in this filing
Maloberti Renaud Bertrand · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-17 | Sale : show line 1 in the form | −25,000 | $0.73 | $18,250 | 41,580 | D |
| Open-market sales · 25,000 sh · avg $0.73 · $18,250 | ||||||
Loading xslF345X03/doc4.xml…